Feed TMO
TM

Thermo Fisher Scientific

TMO · NYSE

$613.69 +0.63% (+$3.87)
1M +4.15%
Market Cap $226.6B
P/E Ratio 32.48x
Div. Yield 0.30%
ROE 13.35%

Bulios Fair Price

$471.2

23.2% downside

Trenutna cena

$613.69

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica TMO trenutno precenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Piotroski F-Score Moderate
6/9
Valuation
25 /100
Expensive
P/FCF 30.97x
P/E 32.48x
P/B 4.30x
Growth
24 /100
Declining
FCF growth 3.07%
EPS growth 0.19%
Book val. growth 6.69%
Profitability
83 /100
Strong
Op. margin 17.69%
Gross margin 40.37%
FCF margin 15.79%
Quality
49 /100
Average
ROA 6.17%
ROIC 7.45%
Asset turnover 0.41x
Debt
54 /100
Moderate
Int. coverage 5.88x
Debt/Equity 0.81x
Net debt/EBITDA 3.52x
Stability
100 /100
Stable
EPS volatility 11.30%
Beta 0.85x
Profitable years 6

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o TMO
Online

O podjetju

Thermo Fisher Scientific Inc. (TMO) is a global biotechnology company focusing on providing a wide range of laboratory technologies, scientific products, and services. The company is a leader in research and development, diagnostics, pharmaceuticals, and biotechnology. Thermo Fisher Scientific offers advanced products for the analysis of DNA, proteins, drugs, and other biological molecules, enabling accelerated scientific discovery and providing customers with tools to improve human health. With its global presence, strong research background, and innovative approach, the company has the potential for further growth and expanding its portfolio of scientific technologies. Investing in Thermo Fisher Scientific Inc. (TMO) shares can be an attractive choice for investors seeking a promising company with high research potential and impact on improving healthcare and scientific knowledge.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Marc N. Casper

Employees

125,000

Headquarters

Waltham

Prihajajoči dogodki

15 SEP.

Ex-Dividend

Ex-dividend date

1d
15 OKT.

Dividend Payment

Datum plačila

31d
28 OKT.

Earnings

Upcoming earnings report

44d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.